Evidence map›Paper›PMID 40087383›Full record

ArticleScientific reports2025

Maternal excess dietary phosphate intake in the periconceptional period is a potential risk for mineral disorders in offspring mice.

Mayu Hayashi-Suzuki, Shiori Fukuda-Tatano, Maki Kishimoto-Ogata, Miyu Ehara-Kawagishi, Hirokazu Ohminami, Masashi Masuda, Yutaka Taketani

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mayu Hayashi-SuzukiDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Shiori Fukuda-TatanoDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Maki Kishimoto-OgataDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Miyu Ehara-KawagishiDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Hirokazu OhminamiDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Masashi MasudaDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan.
Yutaka TaketaniDepartment of Clinical Nutrition and Food Management, Graduate School of Medical Nutrition, Tokushima University Graduate School of Medical Nutrition, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan. taketani@tokushima-u.ac.jp.

Funding

Japan Society for the Promotion of Science 16H03046, 19H04053 and 23K28019
6 · The paper itself

Abstract

Growing consumption of processed foods may cause a greater risk of excessive dietary phosphate intake. The increased dietary phosphate intake as a food additive in the periconceptional period may affect the children's future health. Here, we investigated the effects of maternal excess dietary phosphate intake on offspring in C57BL/6J mice. Female mice were fed a control diet (CP, 0.8% phosphate) or a high-phosphate diet (HP, 1.5% phosphate) for either 21 days during pre-pregnancy or almost 20 days during pregnancy. After weaning, offspring were raised on the CP diet. Relative to the CP groups, offspring from dams fed HP during pre-pregnancy or pregnancy showed decreased urinary phosphate excretion without significant changes in either plasma phosphate level or renal sodium-dependent phosphate transporter mRNA expression at 3 or 10 weeks. However, mRNA expression of intestinal sodium-dependent phosphate transporter was decreased, suggesting that the reduced urinary phosphate excretion was due to decreased absorption of intestinal phosphate. Interestingly, offspring in the HP groups also demonstrated significant differences in plasma levels of parathyroid hormone, fibroblast growth factor 23, and vitamin D. To our knowledge, this is the first report to show that maternal excess intake of dietary phosphate in the periconceptional period disturbs phosphate metabolism in offspring.

Indexed as

Maternal ExposurePhosphatesPrenatal Exposure Delayed EffectsAnimalsDietFemaleFibroblast Growth Factor-23Fibroblast Growth FactorsMaleMiceMice, Inbred C57BLParathyroid HormonePregnancyVitamin DFibroblast Growth Factor-23Fibroblast Growth FactorsParathyroid HormonePhosphatesVitamin DDOHaD hypothesisIntestinal phosphate absorptionMaternal nutritionVitamin D

Identifiers

PMID40087383
PMCPMC11909113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.